Published in Cochrane Database Syst Rev on April 29, 2014
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ (2015) 3.34
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med (2016) 2.54
Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey. BMJ (2016) 2.12
Oral bisphosphonate use and risk of postmenopausal endometrial cancer. J Clin Oncol (2015) 1.97
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach. BMC Cardiovasc Disord (2015) 1.52
Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected]. Medicine (Baltimore) (2014) 1.50
Understanding nutritional epidemiology and its role in policy. Adv Nutr (2015) 1.37
Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One (2015) 1.17
Effectiveness of Case Management for 'At Risk' Patients in Primary Care: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.91
Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann Surg (2016) 0.86
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiol Psychiatr Sci (2016) 0.84
Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports. Mol Psychiatry (2016) 0.83
Atomic data: James Mackenzie Lecture 2015. Br J Gen Pract (2016) 0.82
Perspective: the challenge of clinical decision-making for drug treatment in older people. The role of multidimensional assessment and prognosis. Front Med (Lausanne) (2015) 0.82
Treatment of Hypertensive Patients with a Fixed-Dose Combination of Bisoprolol and Amlodipine: Results of a Cohort study with More Than 10,000 Patients. Cardiol Ther (2015) 0.78
Dysthymia increases the risk of temporomandibular disorder: A population-based cohort study (A STROBE-Compliant Article). Medicine (Baltimore) (2016) 0.77
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. Transl Stroke Res (2015) 0.76
A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs. Clin Epidemiol (2017) 0.75
Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015. J Rheumatol (2017) 0.75
Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis. BMC Health Serv Res (2016) 0.75
Comparison of Estimates between Cohort and Case-Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study. PLoS One (2016) 0.75
Critique of the review of 'Water fluoridation for the prevention of dental caries' published by the Cochrane Collaboration in 2015. Br Dent J (2016) 0.75
Reproducing a Prospective Clinical Study as a Computational Retrospective Study in MIMIC-II. AMIA Annu Symp Proc (2015) 0.75
Statin Treatment and Mortality in Community-Dwelling Frail Older Patients with Diabetes Mellitus: A Retrospective Observational Study. PLoS One (2015) 0.75
Randomized controlled trials: still the backbone of vascular surgery? Gefasschirurgie (2015) 0.75
In search of justification for the unpredictability paradox. Trials (2014) 0.75
A review of routinely collected data studies in urology: Methodological considerations, reporting quality, and future directions. Can Urol Assoc J (2017) 0.75
Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health care. PLoS One (2017) 0.75
Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice. Curr Oncol (2015) 0.75
Big data in healthcare: are we close to it? Rev Bras Ter Intensiva (2016) 0.75
Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage. F1000Res (2016) 0.75
Long-Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility-Reykjavik Study. J Am Geriatr Soc (2016) 0.75
Is long-term use of benzodiazepine a risk for cancer? Medicine (Baltimore) (2015) 0.75
Multiple sclerosis: Switching sides--fingolimod versus injectable MS therapies. Nat Rev Neurol (2015) 0.75
Inhaled nitric oxide and acute kidney injury: new insights from observational data. Crit Care (2017) 0.75
Temporal relationship between dysthymia and temporomandibular disorder: a population-based matched case-control study in Taiwan. BMC Oral Health (2017) 0.75
Reply to G-C Chen et al. Am J Clin Nutr (2016) 0.75
Observational research rigour alone does not justify causal inference. Eur J Clin Invest (2016) 0.75
Marked variation in malignant transformation rates of oral leukoplakia. Evid Based Dent (2015) 0.75
[Pain registries and similar data collections : A systematic review]. Schmerz (2016) 0.75
While modern medicine evolves continuously, evidence-based research methodology remains: how register studies should be interpreted and appreciated. Knee Surg Sports Traumatol Arthrosc (2017) 0.75
Cannabis and Multiple Sclerosis-The Way Forward. Front Neurol (2017) 0.75
What's in a gold standard? In defence of randomised controlled trials. Med Health Care Philos (2017) 0.75
Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study. Br J Cancer (2017) 0.75
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev (2010) 2.11
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
CONSORT 2010. Lancet (2010) 1.50
Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med (2013) 1.39
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials (2009) 1.19
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev (2013) 1.12
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health (2012) 1.05
Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr (2009) 0.98
Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med (2009) 0.93
Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev (2013) 0.88
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr (2012) 0.87
Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One (2009) 0.86
Interactions between non-physician clinicians and industry: a systematic review. PLoS Med (2013) 0.83
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res (2007) 0.83
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res (2012) 0.81
Review of the quality of pediatric medications in developing countries. J Pharm Sci (2013) 0.81
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropr Osteopat (2010) 0.79
A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev (2014) 0.78
Treatment of Kaposi sarcoma in children with HIV-1 infection. Cochrane Database Syst Rev (2014) 0.77
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77
Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom (2017) 0.76
Clarification of study and citation. Arch Intern Med (2007) 0.75
Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect (2014) 0.75
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect (2014) 0.75
Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth (2020) 0.75
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract (2010) 0.75
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev (2016) 0.75
The Cochrane Library Oversight Committee. Cochrane Database Syst Rev (2011) 0.75